PubRank

Arthur E Brown

Author PubWeight™ 41.00‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002 7.81
2 Rhodococcus equi: an emerging pathogen. Clin Infect Dis 2002 2.45
3 Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adults. J Infect Dis 2004 2.01
4 Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX B/E prime-boost HIV-1 vaccine trial in Thailand. Vaccine 2005 1.96
5 A new circulating recombinant form, CRF15_01B, reinforces the linkage between IDU and heterosexual epidemics in Thailand. AIDS Res Hum Retroviruses 2003 1.64
6 Pythium insidiosum pleuropericarditis complicating pneumonia in a child with leukemia. Clin Infect Dis 2002 1.60
7 Cancer surgeons' distress and well-being, II: modifiable factors and the potential for organizational interventions. Ann Surg Oncol 2011 1.50
8 The natural history of HIV-1 infection in young Thai men after seroconversion. J Acquir Immune Defic Syndr 2004 1.44
9 Cancer surgeons' distress and well-being, I: the tension between a culture of productivity and the need for self-care. Ann Surg Oncol 2011 1.43
10 A phase 1/2 comparative vaccine trial of the safety and immunogenicity of a CRF01_AE (subtype E) candidate vaccine: ALVAC-HIV (vCP1521) prime with oligomeric gp160 (92TH023/LAI-DID) or bivalent gp120 (CM235/SF2) boost. J Acquir Immune Defic Syndr 2007 1.39
11 Prevention and treatment of cancer-related infections. J Natl Compr Canc Netw 2008 1.36
12 Safety and immunogenicity of combinations of recombinant subtype E and B human immunodeficiency virus type 1 envelope glycoprotein 120 vaccines in healthy Thai adults. J Infect Dis 2003 1.33
13 Anthrax of the gastrointestinal tract. Emerg Infect Dis 2002 1.24
14 Specific antibody responses to vaccination with bivalent CM235/SF2 gp120: detection of homologous and heterologous neutralizing antibody to subtype E (CRF01.AE) HIV type 1. AIDS Res Hum Retroviruses 2003 1.04
15 HIV/AIDS preventive vaccine 'prime-boost' phase III trial: foundations and initial lessons learned from Thailand. AIDS 2006 0.99
16 Longitudinal study of humoral immune responses in HIV type 1 subtype CRF01_AE (E)-infected Thai patients with different rates of disease progression. AIDS Res Hum Retroviruses 2003 0.92
17 Behavioral and social issues among volunteers in a preventive HIV vaccine trial in Thailand. J Acquir Immune Defic Syndr 2005 0.90
18 HLA class II restriction of HIV-1 clade-specific neutralizing antibody responses in ethnic Thai recipients of the RV144 prime-boost vaccine combination of ALVAC-HIV and AIDSVAX(®) B/E. Vaccine 2011 0.85
19 A standardized regimen of antibiotics prevents infectious complications in skull base surgery. Laryngoscope 2005 0.84
20 Molecular epidemiology of HIV Type 1 in preparation for a Phase III prime-boost vaccine trial in Thailand and a new approach to HIV Type 1 genotyping. AIDS Res Hum Retroviruses 2006 0.84
21 Recruiting volunteers for a multisite phase I/II HIV preventive vaccine trial in Thailand. J Acquir Immune Defic Syndr 2002 0.82
22 The association between hepatitis C virus and HIV-1 in preparatory cohorts for HIV vaccine trials in Thailand. AIDS 2003 0.82
23 Human immunodeficiency virus type 1 primary isolate neutralization resistance is associated with the syncytium-inducing phenotype and lower CD4 cell counts in subtype CRF01_AE-infected patients. J Virol 2003 0.79
24 Heterosexually acquired CRF01_AE/B recombinant HIV type 1 found in Thailand. AIDS Res Hum Retroviruses 2002 0.79
25 HIV epidemic among young Thai Men, 1991-2000. Emerg Infect Dis 2003 0.78
26 QuantiFERON-TB testing for latent tuberculosis infection in low-prevalence countries: making the most of an imperfect process. Infect Control Hosp Epidemiol 2011 0.77
27 High frequency of HIV-1 and hepatitis C co-infection among young Thai men: evidence for a changing pattern of HIV transmission in Thailand. Southeast Asian J Trop Med Public Health 2003 0.77
28 Fever and neutropenia clinical practice guidelines. J Natl Compr Canc Netw 2004 0.77
29 Effect of varicella-zoster virus (VZV) fluorescent-antibody-to-membrane-antigen (FAMA) testing on sensitivity of determining VZV immunity in healthcare workers and on furlough days. Infect Control Hosp Epidemiol 2010 0.77
30 Subtype C/CRF01_AE recombinant HIV-1 found in Thailand. AIDS 2003 0.76
31 Transmission of STLV in a closed colony of macaques. Am J Primatol 2004 0.75
32 A joint clinical research center in Thailand: role in HIV vaccine development. Southeast Asian J Trop Med Public Health 2003 0.75
33 In vitro susceptibility of Thai seronegative donor CD8+ T lymphocytes to human immunodeficiency virus-1 (HIV-1) infection. Asian Pac J Allergy Immunol 2004 0.75
34 Serum levels of MIP-1beta and RANTES in HIV-1 subtype CRF01_AE infected patients with different rates of disease progression. Southeast Asian J Trop Med Public Health 2008 0.75
35 Host genetic analysis of HIV type 1 subtype CRF01_AE (E)-infected Thai patients with different rates of disease progression. AIDS Res Hum Retroviruses 2007 0.75
36 Changes in HIV prevalence among young Thai men as defined by hepatitis C co-infection as a marker for mode of transmission. AIDS 2004 0.75
37 The development of HIV research laboratories in the Royal Thai Army Medical Department. J Med Assoc Thai 2005 0.75